|Day Low/High||0.15 / 0.17|
|52 Wk Low/High||/|
BioCardia, Inc. today announced completion of its merger with Tiger X Medical, Inc.
BioCardia, Inc., a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases, announced today that it has entered into a definitive agreement to merge with Tiger X Medical, Inc.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.